InspireMD (NSPR) Return on Capital Employed Growth (3y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1,962.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 31.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -846.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,318.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -247.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 362.00 |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn | 7,172.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7,172.00 |
| Sep 30, 2025 | 2,236.00 |
| Jun 30, 2025 | 96.00 |
| Mar 31, 2025 | 1,667.00 |
| Dec 31, 2024 | 2,360.00 |
| Sep 30, 2024 | -2,980.00 |
| Jun 30, 2024 | -3,586.00 |
| Mar 31, 2024 | -2,203.00 |
| Dec 31, 2023 | 3,053.00 |
| Sep 30, 2023 | 2,199.00 |
| Jun 30, 2023 | 3,609.00 |
| Mar 31, 2023 | 4,047.00 |
| Dec 31, 2022 | 4,064.00 |
| Sep 30, 2022 | 5,011.00 |
| Jun 30, 2022 | 6,440.00 |
| Mar 31, 2022 | 5,588.00 |
| Dec 31, 2021 | 3,471.00 |
| Sep 30, 2021 | 3,790.00 |
| Jun 30, 2021 | 8,910.00 |
| Mar 31, 2021 | 16,952.00 |
| Dec 31, 2020 | 11,950.00 |
| Sep 30, 2020 | 10,291.00 |
| Jun 30, 2020 | 2,383.00 |
| Mar 31, 2020 | -4,027.00 |
| Dec 31, 2019 | -430.00 |
| Sep 30, 2019 | 26,928.00 |
| Mar 31, 2017 | 1,426.00 |
| Sep 30, 2016 | -28,301.00 |